Co-Authors
This is a "connection" page, showing publications co-authored by Hiroshi Matsui and Olorunseun Ogunwobi.
Connection Strength
0.244
-
Awah CU, Sun Mun J, Paragodaarachchi A, Boylu B, Nzegwu M, Matsui H, Ogunwobi O. Nanocage-incorporated engineered destabilized 3'UTR ARE of ERBB2 inhibits tumor growth and liver and lung metastasis in EGFR T790M osimertinib- and trastuzumab-resistant and ERBB2-expressing NSCLC via the reduction of ERBB2. Front Oncol. 2024; 14:1344852.
Score: 0.244